Ingenium Pharmaceuticals
Latest round
- Series D
Last raised
- Apr 2006
Total raised
- $29M
Investors
- 8
About Ingenium Pharmaceuticals
Ingenium Pharmaceuticals AG, based in Germany, operates in the biotechnology sector by developing advanced solutions for medical diagnostics. Founded in 1998, the company has undergone several operational strategies, including its acquisition by Helmholtz Zentrum in June 2008 for an undisclosed amount. The current CEOs are Heike Lührs and Norman Boss.Ingenium Biologicals Biotech (IBB) specializes in creating advanced biotechnological products, primarily focused on enzyme-linked immunosorbent assay (ELISA) kits, next-generation antibodies, and glycosylation research tools. These products are essential for medical diagnostics and scientific research, addressing crucial healthcare requirements including disease detection, vaccine development, and therapeutic advancements.10, reflecting its business-to-business model focused on sales to research institutions and pharmaceutical partnerships. The company’s revenue generation primarily relies on bulk orders of its ELISA kits and antibody products, with tailored pricing plans based on clients’ needs. The company aims to penetrate additional geographic markets, specifically targeting North America and Asia-Pacific, by 2025. This expansion strategy aligns with Ingenium's objective to strengthen its position in the biotechnology sector following its acquisition in 2008.
Who invested in Ingenium Pharmaceuticals
8 investors across 2 rounds
See all investors in Ingenium Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ingenium Pharmaceuticals
Who invested in Ingenium Pharmaceuticals?
Ingenium Pharmaceuticals has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ingenium Pharmaceuticals raised?
Ingenium Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ingenium Pharmaceuticals last raise money?
Ingenium Pharmaceuticals's most recent round on record is a Series D, in Apr 2006.
What does Ingenium Pharmaceuticals do?
Ingenium Pharmaceuticals AG, based in Germany, operates in the biotechnology sector by developing advanced solutions for medical diagnostics.
Where is Ingenium Pharmaceuticals headquartered?
Ingenium Pharmaceuticals is headquartered in Germany.
Which VCs invest in companies like Ingenium Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Ingenium Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Ingenium Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.